Table 1.

Background of patients in the good obliteration and poor obliteration groups. There were no differences in age, maximum diameter of aneurysm before treatment, the number of smokers, hypertensives, diabetics, dyslipidemics, or the location of the aneurysm, the presence of branch vessels from the aneurysmal dome, the morphology of aneurysms, or residual aneurysm volume 6 months postoperatively between the two groups.

	Good obliteration group (n = 6)	Poor obliteration group (n = 14)	P value
Female sex, n (%)	5 (83.3)	11 (78.5)	0.6
Age, yrs (SD)	55 (±13.9)	66 (±11.3)	0.1
Maximum diameter of aneurysm, mm (SD)	6.4 (±2.3)	5.8 (±0.8)	0.4
Smokers, n (%)	2 (33.3)	1 (7.1)	0.2
Hypertensives, n (%)	2 (33.3)	8 (57.1)	0.3
Diabetics, n (%)	0 (0)	2 (14.2)	0.4
Dyslipidemics, n (%)	0 (0)	6 (42.8)	0.07
Location of aneurysm, n (%)			0.2
Cavenous	1 (16.6)	2 (14.2)
Cave	2 (33.3)	1 (7.1)
Ophthalmic	1 (16.6)	2 (14.2)
Dorsal	1 (16.6)	0 (0)
Superior Hypophyseal Artery	0 (0)	1 (7.1)
Pcom	1 (16.6)	5 (35.7)
Acho	0 (0)	3 (21.4)
Presence of branch vessels from aneurysmal dome, n (%)	2 (33.3)	8 (57.1)	0.3
Morphology of aneurysms, n (%)			0.6
Sacclar	4 (66.6)	10 (71.4)
Fuziform	2 (33.3)	4 (28.5)
Residual aneurysm volume 6 months postoperatively, % (SD)	33.1 (±34.7)	80.6 (±24.8)	0.018